Fortrea Holdings (FTRE) | Financial Analysis & Statements
Fortrea Holdings Inc. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
660.5M
Gross Profit
131.1M
19.85%
Operating Income
8.8M
1.33%
Net Income
-32.5M
-4.92%
EPS (Diluted)
$-0.35
Balance Sheet Metrics
Total Assets
2.7B
Total Liabilities
2.2B
Shareholders Equity
563.5M
Debt to Equity
3.82
Cash Flow Metrics
Operating Cash Flow
120.7M
Free Cash Flow
121.6M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Fortrea Holdings Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2.7B | 2.7B | 3.1B | 3.1B | 3.1B |
| Cost of Goods Sold | 2.2B | 2.2B | 2.6B | 2.4B | 2.5B |
| Gross Profit | 503.8M | 534.2M | 520.4M | 648.7M | 604.4M |
| Gross Margin % | 18.5% | 19.8% | 16.7% | 21.0% | 19.8% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 456.4M | 560.7M | 336.6M | 279.8M | 303.1M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 456.4M | 560.7M | 336.6M | 279.8M | 303.1M |
| Operating Income | -30.6M | -111.8M | 87.4M | 276.2M | 135.0M |
| Operating Margin % | -1.1% | -4.1% | 2.8% | 8.9% | 4.4% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 91.4M | 123.8M | 69.8M | 200.0K | 200.0K |
| Other Non-Operating Income | -861.0M | -39.4M | -16.5M | -39.0M | 1.6M |
| Pre-tax Income | -983.0M | -275.0M | 1.1M | 237.0M | 136.4M |
| Income Tax | 3.2M | -3.5M | 4.5M | 44.1M | 38.4M |
| Effective Tax Rate % | 0.0% | 0.0% | 409.1% | 18.6% | 28.2% |
| Net Income | -986.2M | -328.5M | -3.4M | 192.9M | 98.0M |
| Net Margin % | -36.2% | -12.2% | -0.1% | 6.2% | 3.2% |
| Key Metrics | |||||
| EBITDA | 55.3M | -3.6M | 190.7M | 371.1M | 303.4M |
| EPS (Basic) | $-10.81 | $-3.67 | $-0.04 | $2.18 | $1.11 |
| EPS (Diluted) | $-10.81 | $-3.67 | $-0.04 | $2.18 | $1.11 |
| Basic Shares Outstanding | 91230342 | 89509537 | 88800000 | 88400000 | 88400000 |
| Diluted Shares Outstanding | 91230342 | 89509537 | 88800000 | 88400000 | 88400000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Fortrea Holdings Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 174.6M | 118.5M | 108.6M | 112.0M | 94.6M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 113.6M | 156.5M | 481.0M | 449.2M | 422.5M |
| Inventory | - | - | - | - | - |
| Other Current Assets | 37.6M | 77.2M | 35.1M | 50.8M | 73.1M |
| Total Current Assets | 897.2M | 948.2M | 1.3B | 1.2B | 1.1B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 56.0M | 66.2M | 78.2M | 50.0M | 65.7M |
| Goodwill | 2.5B | 4.1B | 4.8B | 4.8B | 5.1B |
| Intangible Assets | 622.0M | 655.7M | 771.2M | 823.3M | 935.5M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 87.0M | 108.6M | 82.7M | 55.5M | 72.2M |
| Total Non-Current Assets | 1.8B | 2.6B | 3.1B | 3.0B | 3.3B |
| Total Assets | 2.7B | 3.6B | 4.4B | 4.3B | 4.4B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 29.7M | 138.2M | 132.8M | 81.5M | 60.5M |
| Short-term Debt | 14.0M | 88.2M | 45.6M | 23.3M | 24.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 28.2M | 39.0M | 36.0M | 27.1M | 30.2M |
| Total Current Liabilities | 913.3M | 949.5M | 775.9M | 699.0M | 826.7M |
| Non-Current Liabilities | |||||
| Long-term Debt | 1.1B | 1.1B | 1.6B | 40.1M | 53.2M |
| Deferred Tax Liabilities | 97.6M | 121.7M | 148.8M | 184.5M | 210.3M |
| Other Non-Current Liabilities | 39.3M | 35.3M | 61.3M | 21.7M | 17.9M |
| Total Non-Current Liabilities | 1.2B | 1.3B | 1.8B | 246.3M | 281.4M |
| Total Liabilities | 2.2B | 2.2B | 2.6B | 945.3M | 1.1B |
| Equity | |||||
| Common Stock | 100.0K | 100.0K | 100.0K | 0 | - |
| Retained Earnings | -1.4B | -397.0M | -49.1M | 0 | - |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 563.5M | 1.4B | 1.7B | 3.3B | 3.3B |
| Key Metrics | |||||
| Total Debt | 1.1B | 1.2B | 1.7B | 63.4M | 77.2M |
| Working Capital | -16.1M | -1.3M | 477.2M | 547.9M | 290.8M |
Balance Sheet Composition
Fortrea Holdings Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -986.2M | -328.5M | -3.4M | 192.9M | 98.0M |
| Depreciation & Amortization | 78.0M | 86.9M | 96.4M | 92.7M | 166.3M |
| Stock-Based Compensation | 74.4M | 58.4M | 42.7M | 25.4M | 27.5M |
| Working Capital Changes | 75.8M | 457.1M | 18.9M | -115.1M | -154.2M |
| Operating Cash Flow | -774.0M | 272.6M | 140.5M | 208.4M | 142.8M |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Acquisitions | 39.6M | 276.6M | - | 0 | 0 |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | 39.6M | 277.1M | 8.5M | 400.0K | 300.0K |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 453.9M | 826.5M | 1.8B | 0 | 0 |
| Debt Repayment | -529.6M | -1.3B | -179.4M | 0 | 0 |
| Financing Cash Flow | -76.3M | -497.8M | -139.0M | -8.7M | -128.5M |
| Free Cash Flow | 88.3M | 237.3M | 127.1M | 33.1M | 143.3M |
| Net Change in Cash | -810.7M | 51.9M | 10.0M | 200.1M | 14.6M |
Cash Flow Trend
Fortrea Holdings Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
522.33
Forward P/E
10.43
Price to Book
1.62
Price to Sales
0.34
PEG Ratio
-10.76
Profitability Ratios
Profit Margin
-36.21%
Operating Margin
1.33%
Return on Equity
-102.41%
Return on Assets
-0.61%
Financial Health
Current Ratio
0.98
Debt to Equity
198.26
Beta
1.78
Per Share Data
EPS (TTM)
$-10.81
Book Value per Share
$6.05
Revenue per Share
$29.86
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| FTRE | 916.3M | 522.33 | 1.62 | -102.41% | -36.21% | 198.26 |
| Vertex | 109.4B | 28.40 | 5.92 | 22.54% | 32.94% | 10.91 |
| Regeneron | 81.0B | 18.00 | 2.45 | 14.86% | 31.41% | 9.51 |
| Zymeworks | 2.0B | 3.79 | 7.32 | -26.72% | -76.56% | 6.80 |
| Amylyx | 1.9B | 2.54 | 6.31 | -61.59% | 0.00% | 1.95 |
| Syndax | 1.9B | -6.50 | 28.94 | -161.83% | -165.60% | 534.48 |
Financial data is updated regularly. All figures are in the company's reporting currency.






